BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8419113)

  • 1. Ofloxacin treatment of difficult infections of the skin and skin structure.
    Gentry LO; Rodriguez-Gomez G
    Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
    Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
    Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents.
    Eron LJ; Gentry LO
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):435-9. PubMed ID: 1643820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral followed by oral ofloxacin for nosocomial pneumonia and community-acquired pneumonia requiring hospitalization.
    Gentry LO; Rodriguez-Gomez G; Kohler RB; Khan FA; Rytel MW
    Am Rev Respir Dis; 1992 Jan; 145(1):31-5. PubMed ID: 1731595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.
    Drehobl M; Koenig L; Barker M; St Clair P; Maladorno D
    Chemotherapy; 1997; 43(5):378-84. PubMed ID: 9309373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of serious skin and soft tissue infections with ofloxacin administered by intravenous and oral route.
    Lentino JR; Augustinsky JB; Weber TM; Pachucki CT
    Chemotherapy; 1991; 37(1):70-6. PubMed ID: 2013245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of injectable ofloxacin in treating septicemia. Multicenter study].
    Doco-Lecompte T; Modaï J
    Pathol Biol (Paris); 1989 May; 37(5):465-7. PubMed ID: 2674872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of posttraumatic osteitis with intravenous ofloxacin.
    Seibold R; Betz A
    Clin Ther; 1991; 13(4):457-9. PubMed ID: 1933996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
    Powers RD; Schwartz R; Snow RM; Yarbrough DR
    Clin Ther; 1991; 13(6):727-36. PubMed ID: 1790547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
    Nicodemo AC; Robledo JA; Jasovich A; Neto W
    Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone infections: treatment by ofloxacin. Apropos of 10 cases].
    Bernard E; Etesse H; Garraffo R; Giaume F; Dellamonica P
    Pathol Biol (Paris); 1987 May; 35(5):644-7. PubMed ID: 3302877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H; Galanakis N
    Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
    Liam CK; Aziah AM; Lim KH; Wong CM
    Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with parenteral and oral ofloxacin in severe infections.
    Kanellakopoulou K; Giamarellou H
    Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
    Rodriguez-Noriega E; Esparza-Ahumada S; Morfin-Otero R
    J Chemother; 1995 Jun; 7 Suppl 2():155-60. PubMed ID: 8622105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of skin, skin structure, bone, and joint infections with ceftazidime.
    Gentry LO
    Am J Med; 1985 Aug; 79(2A):67-74. PubMed ID: 3895921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
    Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
    Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ofloxacin versus parenteral therapy for chronic osteomyelitis.
    Gentry LO; Rodriguez-Gomez G
    Antimicrob Agents Chemother; 1991 Mar; 35(3):538-41. PubMed ID: 2039205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.